About Zerion Pharma.

Brochure Data from the first human study demonstrate excellent performance
Brochure Zerion Pharma’s Dispersome® technology published in two peer-reviewed papers
Brochure Zerion Pharma and Insud Pharma collaboration
Brochure Zerion Pharma and Hovione to cover use of the Dispersome® in nutraceuticals
Brochure Dispersome® - Make your drug soluble
Brochure Zerion-Hovione Strategic Partnership
Brochure Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement

Arla Foods Ingredients and Zerion Pharma complete long-term supply agreement for beta-lactoglobulin (Lacprodan® BLG-100)
Video Using New Technologies to Improve Formulation of Poorly Soluble Drugs – Does It Matter?

2024-05-21
Video Dispersome® – an amorphous mixture

Technology that is changing the future

DISPERSOME®️ PLATFORM
Our Dispersome®️ platform is based around a class of novel excipients to formulate poorly soluble small molecule drugs into stable amorphous formulations with a high drug load.

IMPROVING OUTCOMESBy increasing solubility and dissolution rate the Dispersome®️ platform aims at improving bioavailability, therapeutic outcomes and convenience for patients.

COMPATIBLE TECHNOLOGY
Dispersome®️ formulations are compatible with standard solid oral dosage form manufacturing processes and facilities.

2021-09-29

CPHI Online is the largest global marketplace in the pharma ingredients industry